Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
The Lancet. Respiratory Medicine|January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trialsClaire Keating, Lael M Yonker, François Vermeulen, et al.Pediatric Pulmonology|April 22, 2022
DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis-associated variants in the Severe Asthma Research ProgramManuel E Izquierdo, Chad R Marion, Wendy C Moore, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 3, 2025
PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop reportSylvia Szentpetery, Dara Riva, Yair J Blumenfeld, et al.The Lancet. Respiratory Medicine|November 7, 2022
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Felix Ratjen, Renee Russell, et al.The Lancet. Respiratory Medicine|February 26, 2023
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trialsAhmet Z Uluer, Gordon MacGregor, Pilar Azevedo, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.Annals of the American Thoracic Society|October 1, 2024
Research Priorities in Pediatric Asthma Morbidity: Addressing the Impacts of Systemic Racism on Children with Asthma in the United States. An Official American Thoracic Society Workshop ReportStephanie Lovinsky-Desir, Isaretta L Riley, Tyra Bryant-Stephens, et al.The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.American Journal of Respiratory Cell and Molecular Biology|October 22, 2025
Design and Characterization of 4D-710, an Aerosolized Gene Therapy for Cystic Fibrosis Lung DiseaseMelissa A Calton, Roxanne H Croze, Theodore H Sullivan, et al.ERJ Open Research|January 15, 2025
The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocolChristine M Liu, Jakob L Fischer, Edith T Zemanick, et al.Pageof 13